RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Bioporto A/S Stock

Bioporto A/S Stocks 2024

Bioporto A/S Stocks

358.5 M

Ticker

BIOPOR.CO

ISIN

DK0011048619

WKN

893191

In 2024, Bioporto A/S had 358.5 M outstanding stocks, a 0% change from the 358.5 M stocks in the previous year.

The Bioporto A/S Stocks history

YEARNUMBER OF STOCKS (undefined DKK)
2025e358.5
2024e358.5
2023358.5
2022331.2
2021278.05
2020213.54
201951.43
201847.43
201743.77
201639.67
2015147.32
2014117.86
201379.14
201259.99
201157.05
201055.79
200951.98
200850.71
200741.73
200632.21
200530.85
200429.38

Bioporto A/S shares outstanding

The number of shares was Bioporto A/S in 2023 — This indicates how many shares 358.498 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Bioporto A/S earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Bioporto A/S's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Bioporto A/S’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Bioporto A/S's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Bioporto A/S Aktienanalyse

What does Bioporto A/S do?

Bioporto A/S is a Danish company specializing in the development, production, and sale of diagnostic products for use in medical diagnostics. It was founded in 1999 and is headquartered in Hellerup, near Copenhagen. The company's history is closely connected to the development and marketing of biomarkers and tests. Biomarkers are biological substances that can serve as indicators for certain diseases or health conditions. Bioporto A/S specializes in the identification and development of these biomarkers, playing an important role in medical diagnostics. Its business model is based on the development and production of medical diagnostic products based on the identification of biomarkers. The company focuses on various sectors such as clinical diagnostics, the life science industry, and research and development in the diagnostic field. Bioporto A/S offers a wide range of products that cater to different customer needs. In the field of clinical diagnostics, the company provides a variety of tests and test kits for the identification of biomarkers. These include tests for determining N-terminal prohormones of brain natriuretic peptides (NT-proBNP), a biomarker used in the diagnosis of heart failure, as well as tests for detecting protein C and S, hormone receptors, or Addison's disease. In the life science industry, Bioporto A/S offers products used in the exploration of biomarkers, antibodies, and proteins. This includes antibodies that can be used for protein and protein complex analysis. Research and development of new biomarkers and diagnostic products are of great importance at Bioporto A/S. The company continually invests in the development of new tests and test kits to expand its product range and meet the ever-growing demands of medical diagnostics. Overall, Bioporto A/S is an innovative company playing an important role in medical diagnostics. With its high-quality products and close collaboration with partners in research and development, Bioporto A/S ensures it will continue to play a significant role in the identification and development of biomarkers and diagnostic products in the future. Bioporto A/S ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Stocks Details

Evaluating Bioporto A/S's Shares Outstanding

Bioporto A/S's shares outstanding refer to the total number of shares that are currently held by all its shareholders, including institutional investors and restricted shares held by the company’s officers and insiders. The number of shares outstanding is crucial in determining the company's market capitalization and is used by investors to assess the company’s size, financial health, and investment potential.

Year-to-Year Comparison

Tracking the changes in Bioporto A/S’s shares outstanding over the years can provide investors with insights into the company's financial strategies and market valuation. An increase in shares outstanding can result from actions like issuing new shares, while a decrease can result from buybacks.

Impact on Investments

For investors, understanding Bioporto A/S’s shares outstanding is essential for evaluating its earnings per share (EPS) and market valuation. A change in the number of shares outstanding can impact the EPS, which is a significant driver of stock prices and investor decisions.

Interpreting Changes in Shares Outstanding

Variances in Bioporto A/S’s shares outstanding can signal shifts in the company’s financial strategy. An increase may dilute the EPS and share value, indicating potential fundraising or acquisitions. Conversely, a decrease, often due to share buybacks, can enhance share value and indicate the company’s confidence in its financial performance.

Frequently Asked Questions about Bioporto A/S stock

How many stocks are there of Bioporto A/S?

The current number of stocks of Bioporto A/S is 358.5 M undefined.

What does Number of Shares / OutstandingShares mean?

The outstanding shares (or issued shares) of Bioporto A/S are the total number of shares issued and actively held by shareholders - both external investors and company insiders. However, these must be actual shares. may grant stock options to executives that can be converted into shares.

How has the number of shares of Bioporto A/S evolved in recent years?

The number of shares of Bioporto A/S has increased by 0% gestiegen compared to last year.

What does the number of shares mean for investors?

The number of shares outstanding is used to calculate key metrics such as a company's market capitalization, earnings per share (EPS), and cash flow per share (CFPS). The number of outstanding shares of a company is not static and can fluctuate greatly over time.

Why does the number of stocks fluctuate?

There are various factors that can lead to a change. Bioporto A/S as a company can issue new shares, carry out stock splits or reverse splits.

Does the number of shares have an impact on the performance of Bioporto A/S?

There is no tangible long-term evidence or study that stocks with a certain number of shares (regardless of Mega/Large/Mid/Small Cap) would yield significantly higher returns than others. There are occasional small studies (limited number of stocks, short investment period) that certain classes outperform or have higher risk, but none of them are 1. conclusive (cause-effect is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).

How much dividend does Bioporto A/S pay?

Over the past 12 months, Bioporto A/S paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Bioporto A/S is expected to pay a dividend of 0 DKK.

What is the dividend yield of Bioporto A/S?

The current dividend yield of Bioporto A/S is .

When does Bioporto A/S pay dividends?

Bioporto A/S pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Bioporto A/S?

Bioporto A/S paid dividends every year for the past 0 years.

What is the dividend of Bioporto A/S?

For the upcoming 12 months, dividends amounting to 0 DKK are expected. This corresponds to a dividend yield of 0 %.

In which sector is Bioporto A/S located?

Bioporto A/S is assigned to the 'Health' sector.

Wann musste ich die Aktien von Bioporto A/S kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Bioporto A/S from 7/27/2024 amounting to 0 DKK, you needed to have the stock in your portfolio before the ex-date on 7/27/2024.

When did Bioporto A/S pay the last dividend?

The last dividend was paid out on 7/27/2024.

What was the dividend of Bioporto A/S in the year 2023?

In the year 2023, Bioporto A/S distributed 0 DKK as dividends.

In which currency does Bioporto A/S pay out the dividend?

The dividends of Bioporto A/S are distributed in DKK.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Bioporto A/S

Our stock analysis for Bioporto A/S Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Bioporto A/S Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.